Literature DB >> 12067971

Human cytomegalovirus infection and expression in human malignant glioma.

Charles S Cobbs1, Lualhati Harkins, Minu Samanta, G Yancey Gillespie, Suman Bharara, Peter H King, L Burt Nabors, C Glenn Cobbs, William J Britt.   

Abstract

Malignant gliomas are the most common primary brain tumors in adults, have no known etiology, and are generally rapidly fatal despite current therapies. Human cytomegalovirus (HCMV) is beta-herpesvirus trophic for glial cells that persistently infects 50-90% of the adult human population. HCMV can be reactivated under conditions of inflammation and immunosuppression, and HCMV gene products can dysregulate multiple cellular pathways involved in oncogenesis. Here we show that a high percentage of malignant gliomas are infected by HCMV and multiple HCMV gene products are expressed in these tumors. These data are the first to show an association between HCMV and malignant gliomas and suggest that HCMV may play an active role in glioma pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067971

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  324 in total

Review 1.  Immunotherapy for primary brain tumors: no longer a matter of privilege.

Authors:  Peter E Fecci; Amy B Heimberger; John H Sampson
Journal:  Clin Cancer Res       Date:  2014-11-15       Impact factor: 12.531

Review 2.  Immunotherapy approaches for malignant glioma from 2007 to 2009.

Authors:  Laura A Johnson; John H Sampson
Journal:  Curr Neurol Neurosci Rep       Date:  2010-07       Impact factor: 5.081

Review 3.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 4.  The role of cytomegalovirus in angiogenesis.

Authors:  Patrizia Caposio; Susan L Orloff; Daniel N Streblow
Journal:  Virus Res       Date:  2010-10-01       Impact factor: 3.303

5.  Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.

Authors:  Alexia Ghazi; Aidin Ashoori; Patrick J Hanley; Vita S Brawley; Donald R Shaffer; Yvonne Kew; Suzanne Z Powell; Robert Grossman; Zakaria Grada; Michael E Scheurer; Meenakshi Hegde; Ann M Leen; Catherine M Bollard; Cliona M Rooney; Helen E Heslop; Stephen Gottschalk; Nabil Ahmed
Journal:  J Immunother       Date:  2012 Feb-Mar       Impact factor: 4.456

6.  Multimodal techniques failed to detect cytomegalovirus in human glioblastoma samples.

Authors:  Marie-Pierre Loit; Homa Adle-Biassette; Schahrazed Bouazza; Marie-Christine Mazeron; Philippe Manivet; Jacqueline Lehmann-Che; Natacha Teissier; Emmanuel Mandonnet; Jean-Michel Molina
Journal:  J Neurovirol       Date:  2018-11-05       Impact factor: 2.643

Review 7.  Design and development of therapies using chimeric antigen receptor-expressing T cells.

Authors:  Gianpietro Dotti; Stephen Gottschalk; Barbara Savoldo; Malcolm K Brenner
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity.

Authors:  Nicole A Wilski; Colby Stotesbury; Christina Del Casale; Brian Montoya; Eric Wong; Luis J Sigal; Christopher M Snyder
Journal:  J Immunol       Date:  2020-04-13       Impact factor: 5.422

Review 9.  Peptide vaccines for the treatment of glioblastoma.

Authors:  Adam M Swartz; Kristen A Batich; Peter E Fecci; John H Sampson
Journal:  J Neurooncol       Date:  2014-12-10       Impact factor: 4.130

10.  Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor.

Authors:  Nicole A Wilski; Christina Del Casale; Timothy J Purwin; Andrew E Aplin; Christopher M Snyder
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.